FIELD: biotechnology.
SUBSTANCE: oligonucleotides are discribed that enhance RNase H1 gene expression via targeted contact with natural antisense polynucleotides RNase H1.The present invention also relates to the use of the described oligonucleotides for treatment of diseases and disorders associated with RNase H1 expression.
EFFECT: creation of additional means for treatment of diseases and disorders associated with RNase H1 expression.
30 cl, 1 dwg, 2 ex
Authors
Dates
2017-02-21—Published
2011-01-25—Filed